Podcasts about fccp

Albina Tyker, MD, and Kerri A. Johannson, MD, MPH, join CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss their research into the association between recovery time from exertional desaturation following a 6-minute walk test with disease severity and progression in patients with fibrotic interstitial lung disease. DOI: 10.1016/j.chest.2025.12.023 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

CHEST June 2026, Volume 169, Issue 6 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST June 2026 issue, including an exploration of management and long-term outcomes of persistent tachypnea of infancy across European countries, an investigation into accelerometer-derived measures of daily physical activity in pulmonary arterial hypertension, and more.   Moderator:    Peter Mazzone, MD, MPH, FCCP

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FNCS, FCCM, is joined by Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, and Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, to discuss the 2026 guidelines for neuromuscular blockade in adult patients with acute respiratory distress syndrome. The guidelines, “Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome,” were published in the March issue of Critical Care Medicine. Drs. Sarwal and Erstad discuss how the evidence in two key trials, ACURASYS and PETAL-ROSE, has helped shape the recommendations provided in the SCCM guidelines. Despite how influential these trials were in shaping the recommendations, only conditional recommendations were made due to low or very low quality of evidence. The lack of evidence proved to be a driving factor in including a call to action in the guidelines. Future research priorities largely revolve around precision medicine and finding more patient-specific interventions to improve patient outcomes. Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, is a professor of neurology and the division chair of neurocritical care at Virginia Commonwealth University (VCU) School of Medicine in Richmond, Virginia, USA. She is also an associate editor of Critical Care Medicine, secretary of the American Society of Neuroimaging, and director of VCU-Wake Forest neuro-ultrasound courses. Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, is a tenured professor and interim dean at the University of Arizona R. Ken Coit College of Pharmacy in Tucson, Arizona, USA. He is also a center investigator for the Center for Health Outcomes, a member of the BIO5 Institute and Comprehensive Center for Pain & Addiction and Pharmacoeconomics Research Center, and a codirector for the Arizona Clinical and Translational Research Graduate Certificate Program. Resources referenced in this podcast: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

Originally aired: May 14, 2026  Lilit A. Sargsyan, MD, FCCP, joins CHEST® Journal Podcast Moderator Abhishek Bhardwaj, MD, to discuss her Exhalations article, “My Voice,” and how her journey of self-advocacy while navigating a cancer diagnosis and her experience of immigrating to Russia and the United States influence her ability to empathize with and advocate for her patients.  This episode is part of a new series exploring articles published in the journal's Humanities section.   Moderator:  Abhishek Bhardwaj, MD 

On this special LIVE from HIMSS 2026 Gil is joined by two-time TEDx speaker Christina Madison, PharmD, FCCP, AAHIVP, the founder and CEO of The Public Health Pharmacist, for a candid, wide-ranging conversation about the profession's inflection point. From the chronic misdiagnosis of cardiovascular disease in women, to the existential threat posed by PBMs and automation, to the urgent fight for pharmacist provider status, Dr. Madison articulates a bold vision: community pharmacists aren't just pill dispensers, they are public health's most accessible, underutilized, and undercompensated front line. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

CHEST May 2026, Volume 169, Issue 5 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST May 2026 issue, including an analysis of interactive pathways of key prognostic factors in severe asthma, an investigation of the long-term safety and efficacy of proximal hypoglossal nerve stimulation in OSA, and more.  Moderator:    Peter Mazzone, MD, MPH, FCCP

Listen in as our expert panel covers the latest evidence on using menopausal hormone therapy and nonhormonal options for treatment of vasomotor symptoms (hot flashes, etc). You'll also hear experts discuss treatments for genitourinary symptoms (vaginal dryness, etc) as well as low libido and brain fog.Special guests:Veronica Vernon, PharmD, BCPS, BCACP, MSCP, FAPhA Associate Professor, Chair of Pharmacy PracticeButler UniversitySarah M. Westberg, PharmD, FCCP, BCPSAssociate Dean for Professional Affairs Professor, College of PharmacyUniversity of MinnesotaYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2026.

Alpha-gal syndrome is an emerging and often underrecognized allergy triggered by a tick bite that can cause delayed reactions to red meat and mammalian-derived products. In this episode, host Stacy Lauderdale is joined by clinical experts Zack Stacy and Kyna Henrici to unpack the science behind alpha-gal, its implications in healthcare settings, and the operational challenges providers face in managing this complex condition.    Guest Speakers:   Zachary Stacy, Pharm.D., MS, FCCP, BCPS  Clinical Pharmacy Specialist, Surgery  BJC Health   Kyna Henrici, RN  Medical Evidence Director - Cardiovascular  Vizient, Inc.    Host:    Stacy Lauderdale, Pharm.D., BCPS  AVP, Evidence-Based Medicine  Vizient, Inc.    00:05 – Introduction  Podcast introduction and welcome to VerifiedRx  00:14 – What is alpha-gal syndrome  Overview of alpha-gal syndrome  Delayed allergic reactions after eating red meat  Often linked to tick bites  00:48 – Meet the Guests   Zack Stacy, clinical pharmacy specialist  Kyna Henrici, medical evidence director  01:10 – Understanding the Allergy  Alpha-gal is a carbohydrate in nonprimate mammals that can trigger an allergy in humans  Key difference is delayed reaction timing  Symptoms are not always easy to trace   01:32 – How It Develops  Triggered by tick bites  Immune system produces IgE antibodies   Oral exposure to alpha-gal leads to delayed reactions  IV exposure to alpha-gal can cause immediate reactions  02:17 – Prevalence and Diagnosis Challenges  More common in Midwest and southern United States  Likely underdiagnosed  Often mistaken for general food allergies  Allergy may fade over time  03:07 – Risks in Healthcare Settings  Patient safety concerns beyond food  Mammalian components in medications and devices  Examples include heparin and surgical materials  03:44 – Hidden Medication Risks  Inactive ingredients can be animal derived  Examples include glycerin, lactose, amino acids, stearates  Difficult to identify and track  04:42 – Lack of Transparency  No centralized ingredient database  Sourcing can change frequently  Variability across manufacturers and batches  05:33 – Screening in Surgical Settings  Medication review at NDC level  Identification of active and inactive ingredients  May require contacting manufacturers  06:45 – Timing Challenges  Urgent procedures limit investigation time  Manufacturer responses may take days  Alternative medications often needed  07:14 – Identifying At Risk Patients  Many patients are unaware they have alpha-gal syndrome  Screening includes questions about dairy tolerance  Three patient categories used for evaluation  08:32 – Using Dairy as a Screening Tool   Dairy tolerance helps guide risk level  Food exposure typically higher than medication exposure  Determines need for deeper review  09:12 – Managing Emergencies  Focus shifts from avoidance to risk mitigation  Use of team communication and clear documentation  Preparation for unavoidable exposure  10:03 – Prevention and Preparedness  Stock alpha-gal safe medications when possible  Prepare for allergic reactions with standard treatments  10:47 – Team Based Care Approach  Collaboration across care teams is essential  Premedication strategies may be used  Close monitoring for reactions  11:11 – Gaps in Care  Limited visibility into product ingredients  Need for better labeling and transparency  11:33 – Need for Standardization  Call for clearer guidance and clinician education  Desire for centralized resource for medication ingredients  12:24 – Monitoring Challenges  CDC tracking decreased after privatization of testing  Cases likely still increasing  12:53 – Closing Remarks    Links and Resources: Alpha-gal Syndrome | Alpha-gal Syndrome | CDC    Subscribe Today!  Apple Podcasts  Spotify  YouTube  RSS Feed   

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/KCA865. CME/CPE/IPCE credit will be available until April 30, 2027.Dispensing High-Quality Care for Myelofibrosis: Pharmacist Leadership in Delivering Effective JAKi Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/KCA865. CME/CPE/IPCE credit will be available until April 30, 2027.Dispensing High-Quality Care for Myelofibrosis: Pharmacist Leadership in Delivering Effective JAKi Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/KCA865. CME/CPE/IPCE credit will be available until April 30, 2027.Dispensing High-Quality Care for Myelofibrosis: Pharmacist Leadership in Delivering Effective JAKi Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/KCA865. CME/CPE/IPCE credit will be available until April 30, 2027.Dispensing High-Quality Care for Myelofibrosis: Pharmacist Leadership in Delivering Effective JAKi Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This is my annual Autism Awareness and Acceptance Month episode. This year, I'm joined by returning guest Dr. Brittany Hoffmann-Eubanks. She was on the show in December 2021 to talk about Medical Writing (Episode 127 https://bit.ly/4cIVeBt).   To read the FULL show notes, visit https://www.thepharmacistsvoice.com.  Click the Podcast tab, and select episode 369.   Follow the podcast to get each new episode! Popular links are below.   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Disclaimer: Brittany is joining us today as a pharmacist, a mom, and an advocate for her autistic child. The perspectives and experiences she shares are her own and do not represent her employer or any organization she's affiliated with.   In this episode, we're discussing neuroaffirming care, "dispensing" practical tips to help you better serve patients on the autism spectrum, and providing context to help you understand the broader ecosystem that patients on the spectrum and their caregivers navigate every day. Once you hear about neuroaffirming care, it just might change the way you approach all neurodiverse patients and possibly improve your relationships with them, too.   At the very end of this episode, I give an update about my son Kraig, who is now 23 and has autism.   Take-aways from this episode If you've met one person with autism, you've met one person with autism. Every person with autism is different. Curiosity is a clinical skill. When you're curious, you get the information you need to have positive patient interactions. Presume competence, but verify understanding. Use tools like the teach-back method, especially when a caregiver is involved. Meet patients where they are. Tailor your patient counseling to meet your patient's needs. That might mean slowing down your rate of speech during patient counseling, adjusting your communication style, including a parent or caregiver in the conversation, or being mindful of sensory needs like noise, light, taste, texture, or smell. Social stories are a useful tool. Use pictures paired with statements to help patients on the spectrum learn about a shot or a medication before they experience it. Language matters. People with autism are "people first." Don't objectify or dehumanize them with language - intentionally or accidentally.  Pharmacists are consistent touch points in our fragmented US healthcare system. We may see neurodiverse patients more often than their primary care or other providers see them. You are a constant in someone's life. Think ability first. Think about what you are able to do as that constant in your patient's life. The next time you interact with a patient who is neurodiverse, try doing just one thing differently. Wait a little longer for your patient to respond, ask one more question, use their name, etc. Those small moments may even save you time later. They build trust, prevent confusion, reduce callbacks, and help patients get it right the first time.    These calls to action will make your care more effective, not add additional burdens.   If this episode resonated with you, I'd love to hear from you. Send me a message through social media or the contact form on my website, thepharmacistsvoice.com. Tell me what you learned or how you've applied it in your practice.  If you know a fellow pharmacy professional who needs to hear this episode, please share it with them. Thank you for listening!   Links from this episode  Brittany Hoffman-Eubanks on LinkedIn https://www.linkedin.com/in/brittany-hoffmann-eubanks/  Brittany on Episode 127 of The Pharmacist's Voice Podcast https://bit.ly/4cIVeBt Autism Society of America https://autismsociety.org/ American Pharmacists Association (APhA) https://www.pharmacist.com/  Ohio Pharmacists Association (OPA) https://www.ohiopharmacists.org  The Perrysburg Podcast Episode (Kaizen Educational Group: Helping Children with Learning Differences in Perrysburg) https://www.perrysburgpodcast.com/141    Previous episodes about autism awareness and acceptance The Pharmacist's Voice Podcast Episode 332 - Social Stories for Patients: Getting a Shot (May 2025) https://bit.ly/4dDc6JM  The Pharmacist's Voice Podcast Episode 327 - 2025 Autism Awareness and Acceptance Month Episode - Transition to Adult Services https://bit.ly/3GCzqLc  The Pharmacist's Voice Podcast Episode 273 - 10 lessons I learned from raising a child with autism (2024) https://bit.ly/4aOky6o  The Pharmacist's Voice Podcast Episode 213 - 2023 How is autism connected to The Pharmacist's Voice Podcast? https://bit.ly/3Ai0EAv  The Pharmacist's Voice Podcast Episode 147 - 2022 Autism Awareness and Acceptance Month Solo Episode (pictures on the website) https://bit.ly/3LHcA2E  The Pharmacist's Voice Podcast Episode 146 - 2022: Interview with Dr. Christina Madison, PharmD, FCCP, AAHIVP about Autism Awareness and Acceptance https://bit.ly/3L8Znzt    Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX  ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Pronounce Drug Names Like a Pro © Online Course https://www.kimnewlove.com  ✅ Pharmacist Podcaster Book https://amzn.to/4iAKNBs  ✅ Podcasting Online Course https://www.kimnewlove.com/podcasting  ✅ Private Podcasting Coaching or Consulting https://www.kimnewlove.com/private-coaching  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with my coach, Dave Jackson from The School of Podcasting! Click my affiliate link: https://community.schoolofpodcasting.com/invitation?code=G43D3G  *New 12-4-25*

Want to add keynote speaking to one of the things you offer in addition to consulting or coaching, but lack the clarity and confidence to make that happen? Find out how to overcome that with my guest, Dr. Christina Madison, on today's Consulting Matters podcast. This episode is for anyone who wants to take the stage as a keynote speaker but holds themselves back, feels shy or introverted, and wants to overcome it. Dr. Christina Madison shares how she went from being a pharmacist and academic to where she is today – a sought-after keynote speaker with 200+ TV appearances and multiple appearances on the TEDx stage. On the show she shares practical advice on how to take the stage with confidence, even if you're an introvert and aren't a natural performer. She also shares how to find your core message and the purpose that drives you as a speaker and the change you want to see in the world. So, whether you want to use speaking to get more consulting or coaching clients or become a paid keynote speaker, this episode is for you. Where to dive in: 00:00 - Introduction to Christina Madison 00:35 - Pharmacy Background and Transition 01:47 - From Clinical Work to Advocacy 02:09 - Entertainment Background and Stage Presence 04:19 - Storytelling and Personal Trauma 12:31 - Leaving Academia for Entrepreneurship 16:14 - TEDx Opportunity and New Chapter 19:01 - Personal Stories in Public Health Messaging 23:16 - Addressing Systemic Biases in Healthcare 27:24 - Developing Stage Presence 30:31 - Practical Advice for Aspiring Speakers 34:03 - Roadmap for Building a Speaking Career 39:58 - Crafting a Message Rooted in Issues 44:19 - Bias and Healthcare Advocacy 50:40 - Healthcare as a Human Right 52:11 - Final Words on Opportunity and Passion Next Steps Clarify the message you feel called to share Christina's journey didn't start with confidence, it started with conviction.Ask yourself what you've experienced or observed that feels like, “this shouldn't be this way.”That's often the beginning of a message worth speaking about. Start practicing your voice in low-stakes spaces Before the big stages, Christina practiced in smaller, safer environments.Look for opportunities to share your ideas… whether that's with peers, small groups, or local organizations, so you can refine both your message and your presence over time. Align your message with a clear brand position Once your message starts to take shape, the next step is making sure your brand reflects it. This is where working with Betsy can help you connect the dots, so your speaking, your content, and your offers all reinforce the same clear, compelling position in the market. Book a discovery call or explore my services. Other articles you may enjoy: Do You Love Consulting or Coaching but Hate Marketing? The Consultant or Coaches's C.U.R.E. for Fear & Self-Doubt Starting a Consulting Business: How to Get It Right from Day One The Trust Factor: Why Brand Clarity Matters for Consultants and Coaches with Dr. J.B. Adams The 3 Types of Expertise Every Consultant and Coach Needs to Name and Claim About the guest: Dr. Christina Madison, PharmD, FCCP, AAHIVP is a TEDx speaker, clinical pharmacist, and Founder and CEO of The Public Health Pharmacist®, a public health consulting firm. She specializes in communicable diseases and has over 15 years of experience in public health, along with 200+ national TV appearances sharing her expertise. A recognized leader and award-winning advocate, she has played a key role in vaccine education and distribution, including administering over 12,000 COVID-19 vaccines in Southern Nevada. Dr. Madison is also an Associate Professor at Roseman University and a passionate advocate for underserved and vulnerable communities. https://www.thepublichealthpharmacist.com/ About the host: Betsy Jordyn is a business mentor, brand messaging strategist, and former Disney consultant who helps purpose-driven consultants and coaches build profitable businesses rooted in their unique strengths. With over 20 years in the industry and a knack for turning big ideas into clear positioning, she's your go-to for strategy that aligns with your calling. Work with me: https://www.betsyjordyn.com/services

Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement. You will learn practical strategies to educate patients, help them understand test options and results, and integrate HPV self‑screening into preventive health services in your practice. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTSarah Westberg, PharmD, FCCP, BCPSProfessor & Associate Dean for Professional AffairsUniversity of Minnesota College of PharmacyPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent guideline updates supporting self‑collected HPV testing as part of cervical cancer screening.2. Identify pharmacist‑led strategies to counsel patients on self‑screening options, appropriate follow‑up steps, and considerations related to insurance coverage and reimbursement.Rachel Maynard and Sarah Westberg have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-075-H01-PInitial release date: 4/20/2026Expiration date: 4/20/2027Additional CPE details can be found here.

Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement. You will learn practical strategies to educate patients, help them understand test options and results, and integrate HPV self‑screening into preventive health services in your practice.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTSarah Westberg, PharmD, FCCP, BCPSProfessor & Associate Dean for Professional AffairsUniversity of Minnesota College of PharmacyGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent guideline updates supporting self‑collected HPV testing as part of cervical cancer screening.2. Identify pharmacist‑led strategies to counsel patients on self‑screening options, appropriate follow‑up steps, and considerations related to insurance coverage and reimbursement.Rachel Maynard and Sarah Westberg have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-075-H01-P Initial release date: 4/20/2026Expiration date: 4/20/2027Additional CPE details can be found Follow CEimpact on Social Media:LinkedInInstagram

CHEST April 2026, Volume 169, Issue 4 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST April 2026 issue, including an exploration of inspiratory effort and dynamic transpulmonary driving pressure in extremely preterm infants undergoing noninvasive ventilation, an investigation of comparative outcomes and side effects of immunosuppressants and tumor necrosis factor inhibitors in sarcoidosis, and more.   Moderator:    Peter Mazzone, MD, MPH, FCCP

Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You'll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don't respond to GLP-1 agonists.Special guests:Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity of South Carolina College of PharmacyJennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADMProfessor and the Associate Dean for EducationUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesPanelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure Dr. Jennifer Clements reports relevant financial relationships with Novo Nordisk (Ozempic, Rybelsus), Eli Lilly (Zepbound, tirzepatide) [speakers bureau].The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2026. 

Landing that first job feels like the finish line, but for most young professionals, it is really just the beginning. In this episode, ⁠Xavier Angel⁠, CFP®, ChFC®, CLTC®, sits down with ⁠Christopher Bland⁠, PharmD, FCCP, FIDSA, BCPS, Albert W. Jowdy Professor in Pharmacy Care at the ⁠University of Georgia College of Pharmacy⁠, to unpack the real-world financial questions that pharmacists and other graduates face early in their careers. From understanding compensation packages to negotiating pay, evaluating retirement benefits, and using side income strategically, this conversation helps listeners look beyond the headline salary number and make more informed financial decisions from day one. The episode also dives into one of the biggest mindset shifts young earners need to make: high income does not equal wealth. Chris and Xavier discuss how lifestyle inflation, student debt, and poor planning can quietly eat away at even a strong paycheck, while time, discipline, and consistent investing can build real financial freedom over time. It's a practical, honest conversation designed to help young professionals turn early career income into long-term opportunity. Episode Highlights: Christopher shares the one financial lesson he wished he had fully embraced coming out of school: the more time money has to compound, the more profound the long-term impact. (04:00) Christopher breaks down salary versus hourly pay for new pharmacists, noting how hourly work creates flexibility to earn overtime, shift differentials, and supplemental income. (09:07) Christopher recounts landing his first job at the lowest pay tier and explains why the beginning of a career is the most powerful moment to negotiate compensation. (14:54) Christopher encourages students to lean on faculty and mentors for career opportunities, sharing how he connects students with prospects through his own network. (20:09) Xavier explains the difference between Traditional and Roth 401k contributions and stresses the importance of adding a beneficiary to retirement accounts from day one. (25:52) Christopher uses his son's first paycheck experience to illustrate why new earners need an automated plan for their money from the start. (31:32) Christopher outlines three practical steps for young pharmacists: leverage time for investing, negotiate confidently, and evaluate every aspect of a job beyond salary. (38:26) Key Quotes: “As you are young in your career, be developing skills. Seek out these opportunities, network, because then things will begin to flow to you, especially in years, like three to five.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “No matter what degree of money you're making, if you have a plan, you're automatically giving yourself a raise.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “I want healthcare professionals, pharmacists, to really take ownership of this topic. We work too hard. You've gone to school for too long, to not have a plan for financial freedom and wealth long term.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS Resources Mentioned: ⁠Christopher Bland, PharmD, FCCP, FIDSA, BCPS⁠ ⁠University of Georgia College of Pharmacy⁠ ⁠Erik Garcia, CFP®, BFA⁠ ⁠Xavier Angel, CFP®, ChFC, CLTC⁠ ⁠Plan Wisely Wealth Advisors⁠

Landing that first job feels like the finish line, but for most young professionals, it is really just the beginning. In this episode, Xavier Angel, CFP®, ChFC®, CLTC®, sits down with Christopher Bland, PharmD, FCCP, FIDSA, BCPS, Albert W. Jowdy Professor in Pharmacy Care at the University of Georgia College of Pharmacy, to unpack the real-world financial questions that pharmacists and other graduates face early in their careers. From understanding compensation packages to negotiating pay, evaluating retirement benefits, and using side income strategically, this conversation helps listeners look beyond the headline salary number and make more informed financial decisions from day one. The episode also dives into one of the biggest mindset shifts young earners need to make: high income does not equal wealth. Chris and Xavier discuss how lifestyle inflation, student debt, and poor planning can quietly eat away at even a strong paycheck, while time, discipline, and consistent investing can build real financial freedom over time. It's a practical, honest conversation designed to help young professionals turn early career income into long-term opportunity. Episode Highlights: Christopher shares the one financial lesson he wished he had fully embraced coming out of school: the more time money has to compound, the more profound the long-term impact. (04:00) Christopher breaks down salary versus hourly pay for new pharmacists, noting how hourly work creates flexibility to earn overtime, shift differentials, and supplemental income. (09:07) Christopher recounts landing his first job at the lowest pay tier and explains why the beginning of a career is the most powerful moment to negotiate compensation. (14:54) Christopher encourages students to lean on faculty and mentors for career opportunities, sharing how he connects students with prospects through his own network. (20:09) Xavier explains the difference between Traditional and Roth 401k contributions and stresses the importance of adding a beneficiary to retirement accounts from day one. (25:52) Christopher uses his son's first paycheck experience to illustrate why new earners need an automated plan for their money from the start. (31:32) Christopher outlines three practical steps for young pharmacists: leverage time for investing, negotiate confidently, and evaluate every aspect of a job beyond salary. (38:26) Key Quotes: “As you are young in your career, be developing skills. Seek out these opportunities, network, because then things will begin to flow to you, especially in years, like three to five.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “No matter what degree of money you're making, if you have a plan, you're automatically giving yourself a raise.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS “I want healthcare professionals, pharmacists, to really take ownership of this topic. We work too hard. You've gone to school for too long, to not have a plan for financial freedom and wealth long term.” - Christopher Bland, PharmD, FCCP, FIDSA, BCPS Resources Mentioned: Christopher Bland, PharmD, FCCP, FIDSA, BCPS University of Georgia College of Pharmacy Erik Garcia, CFP®, BFA Xavier Angel, CFP®, ChFC, CLTC Plan Wisely Wealth Advisors

In this episode of the AARC Perspectives podcast, recorded live at Congress 2025, we talk with past APEX designees Felix Khusid, BS, RRT‑ACCS, RRT‑NPS, RPFT, FAARC, FCCM, FCCP, ATSF (New York–Presbyterian Brooklyn Methodist Hospital), Emilee Lamorena, MSc, RRT, RRT-NPS, FAARC (CHOC Children's), and Andy Klein, MS, RRT, RRT-ACCS, RRT-NPS, AE-C, FCCP (Rush University). They explore the transformative impact of the APEX designation on respiratory departments, emphasizing its role in elevating standards, attracting top talent, and enhancing departmental recognition. In addition, they share tips for overcoming challenges in documentation collection and for fostering employee engagement throughout the Apex process. This episode is a must-listen for respiratory leaders who want to pursue the APEX designation and elevate their departments to national prominence.Send us your thoughts on this podcast

CHEST March 2026, Volume 169, Issue 3       CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2026 issue, including an investigation into a specialist dietary intervention in patients with fibrotic interstitial lung disease experiencing weight loss, an examination of the impact of dual cannabis and tobacco smoking in young patients with lung cancer, and more.  Moderator:    Peter Mazzone, MD, MPH, FCCP

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast. The Points of CARE, the official podcast of Diabetes, Obesity, and Cardiometabolic CARE, will highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. In this special inaugural episode, host Richard Beaser, MD also discusses the ADA's Obesity Association and the "Standards of Care in Overweight and Obesity." 4:15 Beaser speaks with Alissa Segal, PharmD, RPh, CDCES, CDTC, FCCP. Dr. Segal is editor in chief of Diabetes, Obesity, and Cardiometabolic CARE and professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences. Her editorial, "Diabetes, Obesity, and Cardiometabolic CARE: Building New From a Strong Foundation," is available for free at doi.org/10.2337/doci25-0010. 13:00 Samar Hafida, MBCCh, joins the conversation. Dr. Hafida is a board-certified endocrinologist and weight management specialist at Boston Medical Center and assistant professor of medicine (Endocrinology, Diabetes, Nutrition & Weight Management) at the Boston University Chobanian & Avedisian School of Medicine. She is also vice president of the ADA's Obesity Association. Her editorial, "Introducing the Obesity Association and the Launch of Our Official Journal," is available for free at doi.org/10.2337/doci25-0012. 17:55 Dr. Hafida discusses "Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity." This article is available for free at doi.org/10.2337/doci25-0008. 20:05 Richard and Alissa highlight a few articles from the first issue of Diabetes, Obesity, and Cardiometabolic CARE. Simpkins et al. "Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy" doi.org/10.2337/doc25-0051 Livingston et al. "The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program" doi.org/10.2337/doci25-0005. Davidson et al. "Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin" doi.org/10.2337/doc25-0018 Ali et al. "Patterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity" doi.org/10.2337/doc25-0026 Masiano et al. "Type 2 Diabetes Treatment and Experience With Hospitalization in Older Adults: A Convergent Mixed-Methods Study" doi.org/10.2337/doc25-0009 Young et al. "The Critical Role of Diabetology Pharmacists in Improving Cardiovascular-Kidney-Metabolic Care and Outcome" doi.org/10.2337/doc25-0049 To learn more about Diabetes, Obesity, and Cardiometabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

In this episode of SleepTech Talk, we're joined by TV personality and sleep expert Dr. Raj Dasgupta to discuss the latest updates in sleep medicine and sleep apnea care.Dr. Raj Dasgupta, MD, FACP, FCCP, FAASM is a board certified, pulmonary, critical care, internal medicine and sleep specialist known for his appearances on “The Doctors” and “Chasing the Cure.” He brings a unique perspective that blends clinical expertise with clear, practical advice for patients and professionals alike.⭐ In this conversation, we cover:Major updates shaping the field of sleep medicineWhat actually works for better sleep vs common myths and trendsHot topics patients ask about mostNew and evolving treatments for sleep apneaHow clinicians and patients can stay grounded as sleep science evolvesThis episode is perfect for sleep professionals, clinicians, and anyone trying to make sense of today's sleep advice in a rapidly changing landscape.ABOUT SLEEPTECH TALKSleepTech Talk brings together leaders in sleep medicine, technology, and innovation to explore the tools and trends shaping the future of sleep health.Catch the show on most podcast platforms or on YouTubewww.youtube.com/@sleeptechtalk A huge thanks to our sponsors:Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 117The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

Hemang Yadav, MBBS, joins CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss his research into the magnitude and determinants of diffusing capacity for carbon monoxide intersession variability in routine clinical practice and evidence-based thresholds that can guide interpretation of serial measurements. DOI: 10.1016/j.chest.2025.09.006 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

James Cheng Chung Wei, MD, PhD, and Po-Cheng Shih, MD, join CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss their research into the comparative effectiveness and safety of tocilizumab and rituximab in patients with rheumatoid arthritis-associated interstitial lung disease.   DOI: 10.1016/j.chest.2025.09.009 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

CHEST February 2026, Volume 169, Issue 2       CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.     Moderator:    Peter Mazzone, MD, MPH, FCCP

CHEST January 2026, Volume 169, Issue 1       CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST January 2026 issue, including an exploration of intermittent asthma and risk of severe exacerbation in children, an examination of the use of ceftriaxone to prevent early-onset pneumonia in patients following out-of-hospital cardiac arrest, and more.       Moderator:    Peter Mazzone, MD, MPH, FCCP

CHEST December 2025, Volume 168, Issue 6       CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST December 2025 issue, including an exploration of the relationship between inflammation and mucociliary clearance in chronic respiratory conditions, an investigation into the association of hypoxic burden with major cardiovascular events, and more.       Moderator:    Peter Mazzone, MD, MPH, FCCP

Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum disorder. This course explores the clinical distinctions between autism and cerebral folate deficiency, reviews key evidence behind leucovorin use, and outlines counseling considerations relevant to pharmacy practice. You will gain clarity on this complex and evolving topic to better support informed, evidence-based care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterRachel Maynard and Geoff Wall have no relevant financial relationships to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current clinical evidence related to the use of leucovorin in autism and cerebral folate deficiency.2. Identify key counseling considerations for pharmacists discussing leucovorin therapy with patients and caregivers.0.05 CEU/0.5 HrUAN: 0107-0000-25-363-H01-PInitial release date: 12/1/2025Expiration date: 12/1/2026Additional CPE details can be found here.

Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum disorder. This course explores the clinical distinctions between autism and cerebral folate deficiency, reviews key evidence behind leucovorin use, and outlines counseling considerations relevant to pharmacy practice. You will gain clarity on this complex and evolving topic to better support informed, evidence-based care. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterRachel Maynard and Geoff Wall have no relevant financial relationships to disclose.  CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current clinical evidence related to the use of leucovorin in autism and cerebral folate deficiency.2. Identify key counseling considerations for pharmacists discussing leucovorin therapy with patients and caregivers.0.05 CEU/0.5 HrUAN: 0107-0000-25-363-H01-PInitial release date: 12/1/2025Expiration date: 12/1/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Today we are bringing you a conversation on the evolving landscape for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) treatment. Ryan Haumschild, PharmD, MS, MBA, vice president of ambulatory pharmacy at Emory Healthcare and Winship Cancer Institute, spoke with Marilyn Glassberg, MD, the John W. Clarke Professor and Chair of medicine at Loyola University Chicago Stritch School of Medicine; Ayodeji Adegunsoye, MD, MSc, PhD, FACP, FCCP, assistant professor at the University of Chicago; and Janet Pope, MD, MPH, professor of medicine and division member of rheumatology at the University of Western Ontario in Canada. IPF and PPF are increasingly prevalent conditions that pose a growing burden on both patients and health care systems. Despite the availability of FDA-approved antifibrotic therapies, the median survival for patients with IPF and PPF remains less than 5 years after diagnosis—underscoring the critical unmet needs that persist in this field. The panelists discussed the impact these conditions have on patients' lives, evaluated emerging agents, and addressed economic considerations that affect treatment decisions and health care resource allocation.

Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey. Guests: Ting Bao, MD, MS, FSIO Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living Member of the Faculty, Harvard Medical School Dana-Farber Cancer Institute Jun J. Mao, MD, MSCE Chief, Integrative Medicine Service Laurance S. Rockefeller Chair in Integrative Medicine Professor of Medicine, Weill Cornell Medicine Memorial Sloan Kettering Cancer Center Lisa Davis, PharmD, FCCP, BCPS, BCOP, Clinical Professor, Pharmacy Practice & Science The University of Arizona, R. Ken Coit College of Pharmacy

ASHP's senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Before every breakthrough in oncology, there's phase I research — where innovation, teamwork, and patient trust come together.In this episode, Dr. R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO, Vice President of Clinical Research and Executive Director of the Emory Clinical Research Office, joins hosts Ginger Blackmon, PharmD, and Maddy Floysand, PharmD, for an inside look at how early-phase clinical trials lay the groundwork for new cancer therapies.Dr. Harvey, also Professor of Hematology/Medical Oncology and Pharmacology and Associate Dean for Clinical Research at Emory University, shares how phase I studies are evolving to balance discovery, safety, and patient care while expanding access beyond academic centers.He talks about:How early-phase trials shape the future of oncology treatmentsCollaboration between academic and community sites to improve access and equityThe vital role of pharmacists in study design, safety, and educationHow AI and data are changing trial design and patient matchingAdvice for clinicians and students interested in research careersDr. Harvey also reflects on the teamwork that drives meaningful progress and what continues to inspire him after decades of leading research that connects science to patient impact.

ASHP's Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Shaurya Taran, MD, joins CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss his research into the association between low-tidal-volume ventilation and mortality in patients with acute brain injuries receiving mechanical ventilation.   DOI: 10.1016/j.chest.2025.06.042 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. 

CHEST November 2025, Volume 168, Issue 5  CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST November 2025 issue, including an investigation into oxygen saturation targets and neurologic outcomes after cardiac arrest, an exploration of the association of shared decision-making with long-term adherence to lung cancer screening, and more.    Moderator:    Peter Mazzone, MD, MPH, FCCP

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

About this episode: Pharmacies do a lot more than dispense medications. In this episode: Christina Madison, known online as the Public Health Pharmacist, explains how pharmacists and pharmacies are able to support critical health needs in communities across the country. Guest: Christina Madison, PharmD, FCCP, is a clinical pharmacist and the founder and CEO of The Public Health Pharmacist, PLLC. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: The Public Health Pharmacist—http://thepublichealthpharmacist.com The Public Health Pharmacist—Instagram Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

CHEST October 2025, Volume 168, Issue 4  CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST October 2025 issue, including an exploration of the association of physical frailty with incidence and life expectancy of COPD, an investigation of the health and utilization burden of OSA among US active-duty military personnel, and more.     Moderator:    Peter Mazzone, MD, MPH, FCCP

On this milestone episode of Unscripted, the AMCP Podcast, they celebrate the 30th anniversary of the Journal of Managed Care & Specialty Pharmacy (JMCP). Host Susan Cantrell, AMCP CEO, is joined by Laura Happe, PharmD, MPH, Editor-in-Chief of JMCP, and Pat Gleason, PharmD, BCPS, FCCP, FAMCP, Assistant Vice President, Health Outcomes at Prime Therapeutics to reflect on the journal's evolution from its 1995 launch to today's leading voice in managed care pharmacy. Highlights include JMCP's role in shaping policy, advancing research, and tackling pressing issues such as drug pricing, equity, and access—while looking ahead to the future of pharmacy innovation and collaboration. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

ASHP's senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Stephen Eckel, PharmD, MHA, FAPhA, FASHP, FCCP, is the Associate Dean for Global Engagement and an Associate Professor at the UNC Eshelman School of Pharmacy. He is the Residency Program Director for the Health System Pharmacy Administration and Leadership Residency at UNC Medical Center (he was also my RPD!). Dr. Eckel is also the co-founder of ChemoGlo and founder of Assure Medical Technologies, LLC. We talk through leadership training and his involvement in FIP and global pharmacy practice. In addition, he has a passion for entrepreneurship and we talk through how he has identified business opportunities and has created successful companies from them. It's a jam packed episode and one you don't want to miss!

In this important episode of Transmission Interrupted, host Jill Morgan is joined by a distinguished panel of experts to provide a comprehensive update on respiratory illness trends for the 2025 season. Dr. Ryan Maves (infectious diseases and critical care medicine, Wake Forest University), Dr. Kari Simonson (pediatric infectious diseases, University of Nebraska Medical Center), and Dr. John Horton (clinical affairs, gynecology and obstetrics, Emory University) share the latest data and evidence-based recommendations for healthcare providers and the public.The discussion covers the full spectrum of respiratory viruses currently impacting our communities, including influenza, RSV, COVID-19, and pertussis. The panel addresses the unique risks facing infants, children, pregnant individuals, older adults, and those with underlying health conditions. Listeners will gain valuable insight into current vaccine guidance, the role of updated testing strategies, and protective measures that go beyond vaccination—such as proper mask use, respiratory and hand hygiene, and the importance of source control and eye protection.This episode offers practical guidance for both healthcare workers and the public as we enter another busy respiratory virus season. Drawing on real-world experience and the latest research, our guests emphasize steps we can all take to reduce transmission, protect vulnerable populations, and maintain safety in both clinical and home settings.GuestsJohn Patrick Horton, MD, MBAVice Chair of Clinical Affairs for Gynecology and Obstetrics Emory UniversityDr. John Horton is the Vice Chair of Clinical Affairs for Emory University's Department of Gynecology and Obstetrics. He also serves as Emory Healthcare's Division Director for General Gynecology and Obstetrics, and Interim Operations Director for the Gynecologic Specialties Division. Additionally, Dr. Horton is the Director of the Obstetric Rapid Response Team at Emory Healthcare and is Associate Professor at the Emory University School of Medicine Department of Gynecology and Obstetrics. Ryan Maves, MD, FCCM, FCCP, FIDSAProfessor in Infectious Disease and Critical Care MedicineOffice of Global HealthWake Forest UniversityDr. Ryan Maves is a Professor of Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where he serves as medical director of transplant infectious diseases and as a faculty intensivist at North Carolina Baptist Hospital. A graduate of the University of Washington School of Medicine, he entered active duty in the U.S. Navy in 1999. He completed his residency in internal medicine and fellowships infectious diseases and critical care medicine at Naval Medical Center San Diego. During his military service, he served as the flight surgeon for Carrier Air Wing SEVENTEEN embarked onboard the USS George Washington (CVN-73), at the Naval Medical Research Unit No. 6 in Lima, Peru, conducting preclinical and clinical studies in antimicrobial drug resistance and vaccine development, as director of medical services at the NATO Role 3 Multinational Medical Unit at Kandahar Airfield, Afghanistan, and as ID division chief and fellowship director in San Diego. He retired from active duty in 2021 and joined the faculty at Wake Forest. He is the chair of the ABIM Critical Care Medicine Examination Board, co-chair of the SCCM Congress Program Committee, and Chair-Elect of the Chest Infections and Disaster Response Network in CHEST, as well as deputy editor for outreach for the journal CHEST and contributing editor for Critical Care Explorations. He is an author of over 150 scientific manuscripts, 15 textbook chapters, and 100 conference abstracts and invited lectures. He lives in Winston-Salem with his wife, Robin, whom he met in the traditional manner (in the ICU, next to a...

We chat about neuromuscular blockade, monitoring, and reversal in the ICU, including why sugammadex isn't more widely used, with Sara J Hyland, PharmD, BCCCP, FCCP, researcher and clinical pharmacist in perioperative and emergency medicine. Learn more at the Intensive Care Academy! Takeaway lessons References